Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zoafit is a multi-ingredient nutraceutical supplement marketed by Fema Health Care, primarily positioned for women's health and reproductive support. While the brand name is also associated with formulations for male fertility in the broader Indian market, Fema Health Care specifically lists Zoafit Capsules within its women's health portfolio. The product typically functions as an antioxidant and metabolic support supplement, often containing ingredients such as Myo-inositol, Coenzyme Q10 (Ubiquinol), and various vitamins and minerals. These components are intended to improve cellular energy metabolism, reduce oxidative stress, and support hormonal balance, which is particularly relevant in conditions like Polycystic Ovary Syndrome (PCOS) or general reproductive wellness. As a nutraceutical, it is distributed as an oral capsule and is not classified as a pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zoafit.